IFNA1 and COVID-19: In a descriptive review of the literature on the role of IFN-I in treating COVID-19, a positive outcome of IFN-α and IFN-β, administered via inhalation or intramuscularly in the early phase of COVID-19, was observed [16,17,18,19].